Updates

July 13, 2020July 13, 2020
Hulio, Humira Biosimilar, Approved But Not Available Until 2023

The U.S. Food and Drug Administration (FDA) has approved Hulio, a biosimilar of Humira (adalimumab), to treat chronic inflammatory disorders such as ankylosing spondylitis. However, Hulio (adalimumab-fkjp) ... Read more
July 9, 2020July 9, 2020
National Survey Seeks to Assess Full Social, Economic Burdens of Rare Diseases in US

The EveryLife Foundation for Rare Diseases has launched a nationwide National Burden of Rare Disease Survey to measure the full implications, economic and social, ... Read more
July 6, 2020July 6, 2020
CHMP Favors At-home Injection Form of Remsima for Europe

The Committee for Medicinal Products for Human Use (CHMP), a branch of the European Medicines Agency (EMA), is recommending the use of a subcutaneous ... Read more
June 23, 2020June 23, 2020
Alexion Charitable Foundation Giving $1.1M to Assist Rare Disease Community During Pandemic

The Alexion Charitable Foundation has awarded $1.1 million in grants to programs that support those with rare diseases during the COVID-19 pandemic, the organization ... Read more
June 22, 2020June 22, 2020
Simponi Effective, Including in Patients Who Tried Other TNF Blockers, Data Show

Simponi (golimumab) — a TNF inhibitor — is an effective therapy for people with ankylosing spondylitis (AS) and other chronic inflammatory conditions, regardless of ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

March 7, 2018March 7, 2018

Cosentyx Leads to Long-Term Improvement in AS Patients, Phase 3 Trial Shows

News

Results from a Phase 3 clinical trial show that treatment with Cosentyx (secukinumab) led to fast, significant, and sustained symptom improvement in patients with active ankylosing spondylitis (AS). Improvements were particularly noticeable in patients who had never ... Read more

Updates

Hulio, Humira Biosimilar, Approved But Not Available Until 2023

CHMP Favors At-home Injection Form of Remsima for Europe

Alexion Charitable Foundation Giving $1.1M to Assist Rare Disease Community During Pandemic

Simponi Effective, Including in Patients Who Tried Other TNF Blockers, Data Show

Subscribe to our mailing list

Cosentyx Approved in US to Treat Active nr-axSpA

Nepexto, Enbrel Biosimilar, Approved to Treat Patients in Europe

Coalition Will Address Racial Disparities in Rare Disease Communities

FDA Approves Taltz for Non-radiographic Axial Spondyloarthritis

UK Study Evaluating COVID-19 Lockdown Effect on Musculoskeletal Health

COVID-19 Delaying Rare Disease and Gene Therapy Trials, Pharma Execs Say

Eurordis Urges Expansion of Newborn Screening Initiatives Across Europe

Unity and EU-wide Efforts Focus of Online Rare Disease Meeting

Survey Finds Cimzia Prescriptions for nr-axSpA on the Rise in US

Rare Diseases Clinical Research Network Opens Online Survey on COVID-19

RBP4 Protein Levels May Predict Responses to Humira in AS

Humira, Smoking Can Alter Gut Microbiome in AS, Study Finds

NORD Webinar Outlines COVID-19 Response on Financial, Policy Fronts

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

High Levels of Protein Found in Bones and Gut May Link AS and IBD

NORD Opens COVID-19 Financial Aid Program for Rare Disease Community

TNF Inhibitor Use May Raise Risk of MS and Neuropathy in AS Patients

NORD’s Advice on COVID-19: You’re Stronger Than You Think

CHMP Supports Cosentyx’s Approval in Europe to Treat nr-axSpA

NORD’s Advice on COVID-19: You’re Stronger Than You Think

CHMP Recommends Enbrel Biosimilar Nepexto for Approval in Europe

NORD Partners with ‘Sing Me a Story’ for July 18–20 Living Rare Forum

Kicking Alcohol Changed My Ankylosing Spondylitis Experience

Cosentyx Leads to Long-Term Improvement in AS Patients, Phase 3 Trial Shows

Pin It on Pinterest

Hulio, Humira Biosimilar, Approved But Not Available Until 2023

National Survey Seeks to Assess Full Social, Economic Burdens of Rare Diseases in US

CHMP Favors At-home Injection Form of Remsima for Europe

Alexion Charitable Foundation Giving $1.1M to Assist Rare Disease Community During Pandemic

Simponi Effective, Including in Patients Who Tried Other TNF Blockers, Data Show

Subscribe to our mailing list

Cosentyx Approved in US to Treat Active nr-axSpA

Nepexto, Enbrel Biosimilar, Approved to Treat Patients in Europe

Coalition Will Address Racial Disparities in Rare Disease Communities

FDA Approves Taltz for Non-radiographic Axial Spondyloarthritis

UK Study Evaluating COVID-19 Lockdown Effect on Musculoskeletal Health

COVID-19 Delaying Rare Disease and Gene Therapy Trials, Pharma Execs Say

Eurordis Urges Expansion of Newborn Screening Initiatives Across Europe

Unity and EU-wide Efforts Focus of Online Rare Disease Meeting

Survey Finds Cimzia Prescriptions for nr-axSpA on the Rise in US

Rare Diseases Clinical Research Network Opens Online Survey on COVID-19

RBP4 Protein Levels May Predict Responses to Humira in AS

Humira, Smoking Can Alter Gut Microbiome in AS, Study Finds

NORD Webinar Outlines COVID-19 Response on Financial, Policy Fronts

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

High Levels of Protein Found in Bones and Gut May Link AS and IBD

NORD Opens COVID-19 Financial Aid Program for Rare Disease Community

TNF Inhibitor Use May Raise Risk of MS and Neuropathy in AS Patients

TNF Inhibitors Often Ineffective, Affecting Certain Aspects of Life for AS Patients, Study Says

NORD’s Advice on COVID-19: You’re Stronger Than You Think

CHMP Supports Cosentyx’s Approval in Europe to Treat nr-axSpA

NORD’s Advice on COVID-19: You’re Stronger Than You Think

CHMP Recommends Enbrel Biosimilar Nepexto for Approval in Europe

NORD Partners with ‘Sing Me a Story’ for July 18–20 Living Rare Forum

Kicking Alcohol Changed My Ankylosing Spondylitis Experience

Pin It on Pinterest